CClinicalTrials.gg
Status unknownNCT05434039NPUpdated Jul 27, 2022

Diclofenac Phonophoresis Versus High Power Pain Threshold Ultrasound on Patients With Neck Pain

An interventional study of diclofenac phonophoresis and high power pain threshold ultrasound in Neck Pain, sponsored by Cairo University. Status unknown. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2022-07-27.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

the aim of this study is to investigate the effect of diclofenac phonophoresis versus high power pain threshold ultrasound in patients with mechanical non-specific neck pain

Read the detailed description

Neck pain can be a long-lasting condition, Between half and three quarters of patients with neck pain will experience recurrence within 1-5 years. Costs for the society due to neck pain are consequently high. Neck pain (NP) is one of the common musculoskeletal problems. NP can be caused by the stress over the musculoskeletal system due to postural disorders and may also be associated with other causes such as intervertebral disc herniation, nerve compression, or fracture. Musculoskeletal pain due to trigger points is one of the most prevalent reasons for patients to seek treatment. The aim of physical therapy treatment in patient with myofascial pain syndrome is to reduce the pain and restore normal function. Most physical therapy treatments for MPS are targeted to the deactivation of MTrPs. Physical therapy techniques include manual therapies; such as ischemic compression, spray and stretch, strain and counter strain, muscle energy techniques, trigger point pressure release, transverse friction massage; needling therapies, and other techniques such as thermotherapy, ultrasound therapy , phonophoresis and laser therapy.Due to the semi-solid properties, a special method is needed for transdermal permeation of lidocaine. Therefore, many studies have focused on enhancing the level of transdermal permeation by either changing the physiochemical properties of lidocaine or using physical modalities In particular, there has been considerable interest in transdermal permeation using various methods based on the idea that the amount and depth of transdermal permeation can be increased using various physical modalities. patients with mechanical neck pain will be allocated randomly into three equal groups; group A will receive phonophoresis and traditional therapy, group B will receive high power pain thresholdand traditional therapy and group C will receive traditional therapy

02

Conditions studied

  • Neck Pain

Browse trials for

Keywords

  • phonophoresis
  • high power pain threshold ultrasound
  • neck pain
03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 255 are open to participants now.

This study's planned enrollment of 60 is above the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. diagnosed as non-specific neck pain with upper trapezius and suboccipital muscles active myofascial trigger points less than 3 months of duration and have these criteria: taut band on palpation, hyper sensible tender spot in the taut band, local twitch response referred pain pattern
  2. body mass index from 18 to 25 kg/m2
  3. their ages from 18-30

Exclusion criteria

Exclusion Criteria:

  1. if they had trigger point injections within the past 6 months
  2. history of neck or upper back surgery, trauma or fracture
  3. history of a whiplash injury, skin diseases and lesions, any sensory disturbances, any vascular syndromes, neck and back deformities
  4. cervical radiculopathy, and diagnosis of fibromyalgia syndrome, skin diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    diclofenac phonophoresis

    the patients will receive diclofenac phonophoresis and traditional therapy three times a week for four weeks

    Other: diclofenac phonophoresis · Other: conventional therapy

  • Experimental
    high power pain threshold ultrasound

    the patients will receive high power pain threshold ultrasound and traditional therapy three times a week for four weeks

    Other: high power pain threshold ultrasound · Other: conventional therapy

  • Active comparator
    conventional therapy

    the patients will receive traditional therapy three times a week for four weeks

    Other: conventional therapy

Interventions

  • Otherdiclofenac phonophoresis

    the patients will be in comfortable position and apply diclofenac phonophoresis on upper trapezius and suboccipital muscle by ultrasound device. diclofenac gel was applied circularly with a thickness of 2-3 mm. Then ultrasound with was applied with 1 MHz frequency and 1.5 Wt/cm2 power over the trigger points on the trapezius and suboccipital muscle, for 10 min.

  • Otherhigh power pain threshold ultrasound

    the patients will be in comfortable position and The frequency was set to 1 MHz, and the intensity will be increased from 0.5 to 2 until the patient reported an unpleasant sensation. The probe was held there for 4 s; then, the intensity was reduced by 50%, and the probe will be moved over and around the trigger point. This process is done several times for three minutes

  • Otherconventional therapy

    the patient will receive an active range of motion exercise, stretching and strengthening of all cervical muscles

06

What researchers measure

Primary outcomes

  1. pain intensity

    The scale that will be used is visual analogue scale ;each subject will be instructed to put point on line from no pain to tolerable pain

    Time frame: up to four weeks

Secondary outcomes

  1. cervical range of motion

    range of cervical will be measured by CROM device

    Time frame: up to four weeks

  2. pressure pain threshold

    pressure pain threshold will be measured by commander algometer

    Time frame: up to four weeks

  3. neck disability

    neck disability will be measured by Arabic neck disability index

    Time frame: up to four weeks

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05434039
Lead sponsor
Cairo University
Responsible party
Al Shaymaa Shaaban Abd El Azeim (principle investigator, Cairo University) — Principal investigator
First posted
Jun 27, 2022
Start date
Jul 30, 2022 (estimated)
Primary completion
Sep 1, 2022 (estimated)
Completion
Sep 1, 2022 (estimated)
Last update
Jul 27, 2022

Study contacts

al shaymaa sh abd el azeim, lecturer
Contact
shimaashaaban30@yahoo.com
01033771553
al shaymaa abd el azeim, lecturer
Contact
shimaashaaban30@yahoo.com
01033771553

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion